Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
293 Development of a MUC16-specific CAR-T cell exhibiting potent antitumor activity for the treatment of patients with recurrent ovarian cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
